- Title
- Sofosbuvir plus velpatasvir plus voxilaprevir in DAA failure patients with cirrhosis: Final results of the French compassionate use program
- Creators - without role
- Christophe Hezode - Biomécanique cellulaire et respiratoireDominique Guyader - CIC RennesEric Nguyen-Khac - InsermDominique Larrey - Hôpital Saint EloiRegine Truchi - Centre Hospitalier Universitaire de NiceVincent Di Martino - Centre Hospitalier Universitaire de BesançonYvon Calmus - Assistance Publique – Hôpitaux de ParisAnne Minello FranzaNathalie GiuilySaadi MokhtariKerstin Hartig - Fraunhofer Institute for Open Communication SystemsLaurent Cotte - Hospices Civils de LyonDidier RibardMarc-Antoine Valantin - Charmo UniversityLuminita Bonyhay - Pitié-Salpêtrière HospitalMichel AntoniJean-Pierre Bronowicki - Centre Hospitalier Régional Universitaire de NancyJean-Marc Combis - Hôpital Ambroise-ParéChristophe Pilette - Centre Hospitalier du MansChristophe ZamoraErard DomitilleJean-Pierre ArpurtChristophe Renou - HepatologyMarc Bourliere - Hôpital Saint JosephVeronique Grando - Hôpital Jean-VerdierValerie Canva - Hôpital Claude Huriez
- Publication Details
- Journal of Hepatology, Vol.70(1, 1)
- Identifiers
- 9935354809311
- Academic Unit
- Cell souches plasticité cellul régénérat tissulaire immuno des maladies inflamm - IRMB
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-03590860
Journal article
Sofosbuvir plus velpatasvir plus voxilaprevir in DAA failure patients with cirrhosis: Final results of the French compassionate use program
Journal of Hepatology, Vol.70(1, 1)
2019
Metrics
1 Record Views